![Jakob Loven](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jakob Loven
Directeur/Membre du Conseil chez
Arvinas Operations, Inc.
Profil
Dr. Jakob Loven is on the Board of Directors at Arrakis Therapeutics, Inc., A2 Biotherapeutics, Inc., Arvinas Operations, Inc., Flare Therapeutics, Inc., Hexagon Bio, Inc. and IconOVir Bio, Inc. Dr. Loven was previously employed as an Independent Director by Boundless Bio, Inc., an Independent Director by Arvinas, Inc., a Managing Partner by Nextech Invest AG, a Senior Director-Business Development & Strategy by Relay Therapeutics, Inc., a Senior Associate by Third Rock Ventures LLC, a Co-Founder by Syros Pharmaceuticals, Inc., and an Independent Director by Kronos Bio, Inc. He also served on the board at Kinnate Biopharma, Inc., Vividion Therapeutics, Inc., Turning Point Therapeutics, Inc. and Autolus Therapeutics Plc.
He received his undergraduate degree from the University of Anglia Ruskin and a doctorate degree from Karolinska Institutet.
Postes actifs de Jakob Loven
| Sociétés | Poste | Début |
|---|---|---|
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Directeur/Membre du Conseil | - |
A2 Biotherapeutics, Inc.
 A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Directeur/Membre du Conseil | - |
Arrakis Therapeutics, Inc.
 Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Directeur/Membre du Conseil | 22/04/2019 |
IconOVir Bio, Inc.
 IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Directeur/Membre du Conseil | - |
Flare Therapeutics, Inc.
 Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Directeur/Membre du Conseil | - |
Hexagon Bio, Inc.
 Hexagon Bio, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company that develops microbial genomes into novel therapeutics for oncology and infectious diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Jakob Loven
| Sociétés | Poste | Fin |
|---|---|---|
Nextech Invest AG
 Nextech Invest AG Investment ManagersFinance Nextech invests in companies located in the United States and Europe. The firm focuses on the bio technology sector. It provides financing for early-stage capital requirements. | Private Equity Investor | 01/01/2025 |
| KRONOS BIO, INC. | Directeur/Membre du Conseil | 22/06/2021 |
| KINNATE BIOPHARMA INC. | Directeur/Membre du Conseil | 01/12/2020 |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jakob Loven
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage structure based drug design company for cancer diseases | Health Technology |
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech invests in companies located in the United States and Europe. The firm focuses on the bio technology sector. It provides financing for early-stage capital requirements. | Finance |
Third Rock Ventures LLC
 Third Rock Ventures LLC Investment ManagersFinance Third Rock Ventures invests in companies located in the United States. The firm focuses on the healthcare. It participates in early stage capital requirements. The firm also acts as lead investor. | Finance |
University of Anglia Ruskin
 University of Anglia Ruskin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syros Pharmaceuticals, Inc.
 Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
Relay Therapeutics, Inc.
 Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Arrakis Therapeutics, Inc.
Arrakis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA-targeted small molecules on neurologic diseases, cancer and rare genetic diseases | Health Technology |
Hexagon Bio, Inc.
Hexagon Bio, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company that develops microbial genomes into novel therapeutics for oncology and infectious diseases | Health Technology |
A2 Biotherapeutics, Inc.
A2 Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops cell therapies for cancer treatment | Commercial Services |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
Kronos Bio, Inc.
 Kronos Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel cancer therapeutics | Health Technology |
Boundless Bio, Inc.
 Boundless Bio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that develops cancer therapeutics | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
IconOVir Bio, Inc.
IconOVir Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops oncolytic virus therapy to improve the treatment of patients with cancer | Health Technology |
Flare Therapeutics, Inc.
Flare Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of small molecule medicines | Health Technology |
